Dr Loh Chit Sin

Current Place of Practice

Gleneagles Hospital Kuala Lumpur
Suite 606, Medical Office Block,
282 Jalan Ampang,
50450, Kuala Lumpur
Malaysia
Phone: +603-4253 4460

Certifications

MB ChB (Hons.) Liverpool

MD Liverpool

FRCS Edinburgh

FRCS (Urology)

FAMM

Certified Da Vinci Console Surgeon

Experience

I have more than 20 years experience in all aspects of urology with the exception of paediatric urology and renal transplant. I have a special interest in urological cancers, reconstruction and laparoscopic and robotic surgery. Over the last 5 years, I have developed a subspecialty interest in BPH and prostate cancer. I am a pioneer GreenLight laser surgeon in South East Asia and now serve as a GreenLight laser trainer. I am trained in radioactive seed implantation and robotic prostatectomy and can claim to offer the most comprehensive treatment program for early prostate cancer. Similarly, for renal cancers, I can offer open surgery, laparoscopic surgery and cryosurgery.

Achievements

I felt most flattered when complimented by my Italian sister-in-law for the pizzas I made.

Interests

Classical music, particularly of the classical and romantic periods

Fine dining and fine wines

Chinese history

History of medicine

Travel

Karaoke singing

First Renal Mass Cryosurgery in Malaysia

22th Sep 2011

The first case of cryosurgery for renal mass was successfully carried out in Gleneagles Hospital Kuala Lumpur with the help of Prof. John Ward from MD Anderson Cancer Centre. The patient was a 68-year-old man who was admitted with pneumonia when a 3-cm renal tumour was discovered incidentally in the upper part of his right kidney. The procedure was over in about 2 hours with virtually no blood loss and he was discharged the following day. With this new technology, treatment of small renal tumour can now be done with minimal risk, pain and just an overnight admission. The same technology can be used to treat certain prostate cancers with similar advantages. Outside urology, cryosurgery can also be used to treat certain cancers in the bone,the lung and the liver.

04 October 2011